novartis.comvspfizer.com

Pfizer edges out Novartis significantly on homepage messaging, 69 to 52. Here's where the gap comes from.

Novartis is clearer about what it does (33 vs 19 on clarity). Pfizer has stronger CTAs (75 vs 52). Pfizer is better at saying who it's for (ICP: 15 vs 0). Pfizer's targeting is generic, while Novartis's is absent.

Both sites use the "Community / Movement" positioning archetype — they're competing on the same narrative, which means differentiation has to come from execution, not framing.